Compare

Gilead Sciences vs Moderna

Gilead Sciences (GILD) and Moderna (MRNA) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Gilead Sciences GILDNASDAQ · BiotechnologyModerna MRNANASDAQ · Biotechnology
Insider records, last 12 months226251
Congress trades, last 12 months43
Fund positions reported, last 12 months27633
Federal contract awards, last 12 months00
Open-market purchases by insiders since 200684
Open-market sales by insiders since 20062,8462,760
Last open-market purchase by an insiderFeb 6, 2015Mar 4, 2025
Next resultsOct 22, 2026Oct 29, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Gilead Sciences or Moderna?

Since 2006, Gilead Sciences insiders reported 8 open-market purchases against 4 for Moderna, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade GILD or MRNA?

In the last 12 months, members of Congress disclosed 4 trades in Gilead Sciences (GILD) and 3 in Moderna (MRNA), each reported as a value range on a periodic transaction report.

When did insiders last buy GILD and MRNA?

Gilead Sciences: Feb 6, 2015. Moderna: Mar 4, 2025. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Gilead Sciences free$9.99 a month, cancel anytime

Gilead Sciences pageModerna pageRare insider trades this weekAll comparisons

https://oqro.io/compare/gild-vs-mrna